Saint Paul, MN, United States of America

Peter V Maye


Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 346(Granted Patents)


Company Filing History:


Years Active: 2001-2010

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovation Journey of Inventor Peter V Maye

Introduction:

Peter V Maye, a prolific inventor based in St. Paul, MN (US), has made significant contributions to the field of pharmaceuticals with his groundbreaking patented inventions.

Latest Patents:

Maye holds a total of 8 patents, with his most recent innovations focusing on the development of intermediates for imidazonaphthyridines. These compounds have shown promising capabilities in inducing the biosynthesis of key cytokines like interferon and tumor necrosis factor. Moreover, they exhibit potent antiviral and antitumor properties. The patents also detail methods for preparing these compounds and their intermediates, showcasing Maye's expertise in drug development.

Career Highlights:

Throughout his career, Peter V Maye has been associated with esteemed companies such as 3M Innovative Properties Company and Graceway Pharmaceuticals, LLC. His innovative spirit and dedication to advancing pharmaceutical technologies have earned him a reputable position in the industry.

Collaborations:

Notable collaborations in Maye's career include working alongside accomplished individuals like John F Gerster and Kyle J Lindstrom. These collaborative efforts have led to the successful implementation of groundbreaking ideas and the development of impactful inventions.

Conclusion:

In conclusion, Peter V Maye's relentless pursuit of innovation and his remarkable contributions to the pharmaceutical field through a series of patented inventions highlight his exceptional talent and expertise. His innovative work continues to make a lasting impact on the industry, shaping the future of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…